Eliminating disparities in hypertension care for hispanics and blacks using a heart failure disease management program

Southern Medical Journal

Volumn 104, Issue 8, 2011, Pages 567-573

  Hebert, Kathy ^a   Julian, Elyse ^a   Alvarez, Jorge ^a   Dias, Andre ^a   Tamariz, Leonardo ^a   Arcement, Lee ^a   Quevedo, Henry C ^a  

^a NONE

Author keywords

disease management; disparity; heart failure; hypertension

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG USE; EUROPEAN AMERICAN; FEMALE; HEALTH CARE DISPARITY; HEALTH PROGRAM; HEART EJECTION FRACTION; HEART FAILURE; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RACE DIFFERENCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

AFRICAN AMERICANS; AGED; BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLORIDA; HEALTHCARE DISPARITIES; HEART FAILURE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; LOGISTIC MODELS; LOUISIANA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 80051489640     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318224dd18     Document Type: Article

References (27)

1. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44: 398-404. (Pubitemid 39281486)
2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560-2572.
3. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25: 305-313.
4. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290: 199-206. (Pubitemid 37430058)
5. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106:3068-3072. (Pubitemid 35440290)
6. American Heart Association. Heart Disease & Statistics: 2009 Update At-a-Glance. Circulation 2009;119:480-486.
7. Todd WE, Nash DB. Disease Management: A Systems Approach to Improving Patient Outcomes. New York: John Wiley & Sons, 2001.
8. Bernard DB, Townsend RR, Sylvestri MF. Health and disease management: what is it and where is it going? What is the role of health and disease management in hypertension? Am J Hypertens 1998;11(8 Pt 2): 103S-108S; discussion 109S-111S.
9. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007;115:2761-2788. (Pubitemid 46842793)
10. Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010; 16:e1-e194.
11. Ara S. A literature review of cardiovascular disease management programs in managed care populations. J Manag Care Pharm 2004;10:326-344.
12. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005;111:697-716. (Pubitemid 40216499)
13. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53:e1-e90.
14. Gourley GA, Portner TS, Gourley DR, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998;38:586-597.
15. Bogden PE, Abbott RD, Williamson P, et al. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 1998;13:740-745. (Pubitemid 28523563)
16. Hetlevik I, Holmen J, Kruger O. Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scand Prim Health Care 1999;17:35-40. (Pubitemid 29200197)
17. Fielding JE, Knight K, Mason T, et al. Evaluation of the IMPACT blood pressure program. J Occup Med 1994;36:743-746. (Pubitemid 24219799)
18. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17:140-147. (Pubitemid 27057128)
19. Montgomery AA, Fahey T, Peters TJ, et al. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 2000;320: 686-690. (Pubitemid 30179394)
20. Giles T, Aranda JM Jr, Suh DC, et al. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens (Greenwich) 2007;9:345-354.
21. Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007;55:1056-1065. (Pubitemid 47024610)
22. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007;120:26-32. (Pubitemid 46026987)
23. Poon I, Lal LS, Ford ME, et al. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother 2009;43:185-193.
24. Diaz E, Woods SW, Rosenheck RA. Effects of ethnicity on psychotropic medications adherence. Community Ment Health J 2005;41:521-537. (Pubitemid 41243115)
25. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med 2007;22:1572-1578. (Pubitemid 47568699)
26. Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev 2009;CD004349.
27. Phend C. Lower blood pressure targets offer no benefits. http://www.medpagetoday.com/Nephrology/Hypertension/15003. Published July 8, 2009. Accessed June 26, 2011.